Condition: Hearing Loss · Mild Cognitive Impairment · Alzheimer Disease and Related Dementias (ADRD) · Sponsor: Northwestern University
The goal of this study is to better understand if, in patients with mild to moderate hearing loss who are also experiencing mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (ADRD), Over-the-Counter (OTC) hearing aids: 1. improve communication 2. Whether the magnitude of benefit depends on the patient's level of cognitive disability, 3. Whether alternative remediation (such as targeted communication strategies) offer similar benefits. Participants and a communication partner will be randomized into an OTC first or Communication Strategies first arm, where participants will receive communication strategy information customized for those with cognitive impairment.
This description comes directly from the study's public registry record.
Kendra Marks · 8474670897 · kendra.marks@northwestern.edu
Always discuss trial participation with your own doctor first.
| Northwestern University HA Lab | Evanston, Illinois, United States | Recruiting |
| La Crosse Mayo Clinic | La Crosse, Wisconsin, United States | Enrolling By Invitation |
| UW Madison | Madison, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06112860